A survey by drug maker sanofi-aventis on diabetes and hypertension prevalance in outpatient settings in ten different states in India revealed some preliminary results based on findings from two states - Delhi and Maharashtra. The study "highlights a high percentage of diabetes and hypertension patients who are suffering from associated co-morbidities such as kidney disease, … Continue reading India’s looming healthcare tab from lifestyle diseases
Apothecurry 